Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Conley

Showing results (201-210 of 281) with videos related to

Pageof 29
Sort By:
BMC Psychiatry|February 11, 2011
Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophreniaStephen J Ruberg, Lei Chen, Virginia Stauffer, et al.
Molecular Psychiatry|December 19, 1998
Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 studyR A Lahti, R C Roberts, E V Cochrane, et al.
Lancet (London, England)|January 21, 1995
Homocysteine metabolism in pregnancies complicated by neural-tube defectsJ L Mills, J M McPartlin, P N Kirke, et al.
Mayo Clinic Proceedings|November 6, 2017
An Organization Model to Assist Individual Physicians, Scientists, and Senior Health Care Administrators With Personal and Professional NeedsTait D Shanafelt, Deborah J Lightner, Christopher R Conley, et al.
Cost Effectiveness and Resource Allocation : C/E|April 9, 2009
Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United StatesNicolas M Furiak, Haya Ascher-Svanum, Robert W Klein, et al.
Journal of Clinical Psychopharmacology|November 12, 2005
The prevalence of hyperprolactinemia after long-term haloperidol use in patients with chronic schizophreniaDo-Un Jung, Young-Soo Seo, Jae-Hoon Park, et al.
Journal of Clinical Psychopharmacology|October 2, 2003
Fluoxetine augmentation of haloperidol in chronic schizophreniaJoo-Cheol Shim, Deanna L Kelly, Young-Hoon Kim, et al.
The Journal of Pediatrics|March 6, 2004
Peripheral nerve conduction abnormalities in children exposed to alcohol in uteroMara de los Angeles Avaria, James L Mills, Karin Kleinsteuber, et al.
American Journal of Obstetrics and Gynecology|February 1, 1994
Are obese women at higher risk for producing malformed offspring?D K Waller, J L Mills, J L Simpson, et al.
Journal of Medical Economics|February 7, 2012
Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United StatesHaya Ascher-Svanum, Nicolas M Furiak, Anthony H Lawson, et al.
Pageof 29

Showing results (201-210 of 281) with videos related to

Sort By:
Pageof 29
BMC Psychiatry|February 11, 2011
Identification of early changes in specific symptoms that predict longer-term response to atypical antipsychotics in the treatment of patients with schizophreniaStephen J Ruberg, Lei Chen, Virginia Stauffer, et al.
Molecular Psychiatry|December 19, 1998
Direct determination of dopamine D4 receptors in normal and schizophrenic postmortem brain tissue: a [3H]NGD-94-1 studyR A Lahti, R C Roberts, E V Cochrane, et al.
Lancet (London, England)|January 21, 1995
Homocysteine metabolism in pregnancies complicated by neural-tube defectsJ L Mills, J M McPartlin, P N Kirke, et al.
Mayo Clinic Proceedings|November 6, 2017
An Organization Model to Assist Individual Physicians, Scientists, and Senior Health Care Administrators With Personal and Professional NeedsTait D Shanafelt, Deborah J Lightner, Christopher R Conley, et al.
Cost Effectiveness and Resource Allocation : C/E|April 9, 2009
Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United StatesNicolas M Furiak, Haya Ascher-Svanum, Robert W Klein, et al.
Journal of Clinical Psychopharmacology|November 12, 2005
The prevalence of hyperprolactinemia after long-term haloperidol use in patients with chronic schizophreniaDo-Un Jung, Young-Soo Seo, Jae-Hoon Park, et al.
Journal of Clinical Psychopharmacology|October 2, 2003
Fluoxetine augmentation of haloperidol in chronic schizophreniaJoo-Cheol Shim, Deanna L Kelly, Young-Hoon Kim, et al.
The Journal of Pediatrics|March 6, 2004
Peripheral nerve conduction abnormalities in children exposed to alcohol in uteroMara de los Angeles Avaria, James L Mills, Karin Kleinsteuber, et al.
American Journal of Obstetrics and Gynecology|February 1, 1994
Are obese women at higher risk for producing malformed offspring?D K Waller, J L Mills, J L Simpson, et al.
Journal of Medical Economics|February 7, 2012
Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United StatesHaya Ascher-Svanum, Nicolas M Furiak, Anthony H Lawson, et al.
Pageof 29